Alembic Pharmaceuticals has raised Rs 150 crore through allotted of 1,500 at 8.37% Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of Rs 10 lakh per NCD under Tranche III. The NCD Committee of the Company at its meeting held on March 19, 2019 has allotted the same.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.